Geode Capital Management
PRME icon

Geode Capital Management’s Prime Medicine PRME Stock Holding History

Geode Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.55M Buy
2,743,700
+115,271
+4% +$439K ﹤0.01% 2405
2025
Q4 		$9.12M Buy
2,628,429
+861,533
+49% +$3.83M ﹤0.01% 2455
2025
Q3 		$9.79M Buy
1,766,896
+256,147
+17% +$1.04M ﹤0.01% 2426
2025
Q2 		$3.73M Sell
1,510,749
-15,781
-1% -$24.3K ﹤0.01% 2880
2025
Q1 		$3.04M Buy
1,526,530
+58,924
+4% +$150K ﹤0.01% 2882
2024
Q4 		$4.29M Buy
1,467,606
+107,627
+8% +$378K ﹤0.01% 2813
2024
Q3 		$5.26M Buy
1,359,979
+63,456
+5% +$294K ﹤0.01% 2734
2024
Q2 		$6.67M Buy
1,296,523
+379,662
+41% +$2.3M ﹤0.01% 2573
2024
Q1 		$6.42M Buy
916,861
+29,358
+3% +$223K ﹤0.01% 2564
2023
Q4 		$7.86M Buy
887,503
+40,866
+5% +$315K ﹤0.01% 2466
2023
Q3 		$8.08M Buy
846,637
+306,329
+57% +$3.98M ﹤0.01% 2389
2023
Q2 		$7.92M Buy
540,308
+299,963
+125% +$4.19M ﹤0.01% 2432
2023
Q1 		$2.96M Buy
240,345
+6,050
+3% +$98.6K ﹤0.01% 2865
2022
Q4 		$4.35M Buy
+234,295
New +$4.23M ﹤0.01% 2739

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Geode Capital Management's PRME Position: Q1 2026 in Review

Geode Capital Management increased its Prime Medicine (PRME) stake by 4.4% in Q1 2026, buying an estimated $439K and bringing the position to 2,743,700 shares worth $9.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

Geode Capital Management first reported a position in PRME in Q4 2022 and has held it in 14 quarters since. The position peaked at $9.79M in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Geode Capital Management held 2,743,700 shares of Prime Medicine worth $9.55M as of Q1 2026.
  • Geode Capital Management bought 115,271 Prime Medicine shares in Q1 2026, an estimated $439K.
  • Prime Medicine made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2405 holding.
  • Geode Capital Management first reported a position in Prime Medicine in Q4 2022 and has held it in 14 quarters since.
  • Geode Capital Management's Prime Medicine position peaked at $9.79M in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.